27078619 27286566 27268856 27598560 27792681 28355517 30405624 36711584 26117722 29492273 30125330 32391289 31937648 33807292 26629902 28858725 27475281 35284833 29307225 28861068 26432912 30710128 25790791 26446600 32039686 31985697 31112525 2695720 - Search Results

Year	Number of Results
2015	34
2016	42
2017	39
2018	33
2019	25
2020	18
2021	18
2022	10
2023	3
2024	0

1

Persistent HIV-1 replication during antiretroviral therapy.

Martinez-Picado J, Deeks SG. Martinez-Picado J, et al. Curr Opin HIV AIDS. 2016 Jul;11(4):417-23. doi: 10.1097/COH.0000000000000287. Curr Opin HIV AIDS. 2016. PMID: 27078619 Free PMC article. Review.

2

Viral vectors as vaccine platforms: from immunogenicity to impact.

Ewer KJ, Lambe T, Rollier CS, Spencer AJ, Hill AV, Dorrell L. Ewer KJ, et al. Curr Opin Immunol. 2016 Aug;41:47-54. doi: 10.1016/j.coi.2016.05.014. Epub 2016 Jun 7. Curr Opin Immunol. 2016. PMID: 27286566 Review.

3

New concepts in HIV-1 vaccine development.

Stephenson KE, D'Couto HT, Barouch DH. Stephenson KE, et al. Curr Opin Immunol. 2016 Aug;41:39-46. doi: 10.1016/j.coi.2016.05.011. Epub 2016 Jun 3. Curr Opin Immunol. 2016. PMID: 27268856 Free PMC article. Review.

4

Imaging and tracking HIV viruses in human cervical mucus.

Boukari F, Makrogiannis S, Nossal R, Boukari H. Boukari F, et al. J Biomed Opt. 2016 Sep 1;21(9):96001. doi: 10.1117/1.JBO.21.9.096001. J Biomed Opt. 2016. PMID: 27598560 Free PMC article.

5

Distinct HIV-1 Neutralization Potency Profiles of Ibalizumab-Based Bispecific Antibodies.

Song R, Pace C, Seaman MS, Fang Q, Sun M, Andrews CD, Wu A, Padte NN, Ho DD. Song R, et al. J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):365-373. doi: 10.1097/QAI.0000000000001119. J Acquir Immune Defic Syndr. 2016. PMID: 27792681 Free PMC article.

6

Repurposing a Bacterial Immune System to Discover Antiviral Targets.

Bieniasz P. Bieniasz P. N Engl J Med. 2017 Mar 30;376(13):1290-1291. doi: 10.1056/NEJMcibr1616057. N Engl J Med. 2017. PMID: 28355517 No abstract available.

7

Antibodies and Antibody Derivatives: New Partners in HIV Eradication Strategies.

Carrillo J, Clotet B, Blanco J. Carrillo J, et al. Front Immunol. 2018 Oct 23;9:2429. doi: 10.3389/fimmu.2018.02429. eCollection 2018. Front Immunol. 2018. PMID: 30405624 Free PMC article. Review.

8

Vectored Immunoprophylaxis and Treatment of SARS-CoV-2 Infection.

Tada T, Dcosta BM, Minnee J, Landau NR. Tada T, et al. bioRxiv [Preprint]. 2023 Jan 12:2023.01.11.523649. doi: 10.1101/2023.01.11.523649. bioRxiv. 2023. PMID: 36711584 Free PMC article. Updated. Preprint.

9

Homogeneously modified immunoglobulin domains for therapeutic application.

Liu T, Du J, Luo X, Schultz PG, Wang F. Liu T, et al. Curr Opin Chem Biol. 2015 Oct;28:66-74. doi: 10.1016/j.cbpa.2015.06.007. Epub 2015 Jun 25. Curr Opin Chem Biol. 2015. PMID: 26117722 Review.

10

Rapid Sequencing of Complete env Genes from Primary HIV-1 Samples.

Laird Smith M, Murrell B, Eren K, Ignacio C, Landais E, Weaver S, Phung P, Ludka C, Hepler L, Caballero G, Pollner T, Guo Y, Richman D; IAVI Protocol C Investigators & The IAVI African HIV Research Network; Poignard P, Paxinos EE, Kosakovsky Pond SL, Smith DM. Laird Smith M, et al. Virus Evol. 2016 Jul 8;2(2):vew018. doi: 10.1093/ve/vew018. eCollection 2016 Jul. Virus Evol. 2016. PMID: 29492273 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

211 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Results by year